Navigation Links
Could a cancer drug potentially prevent learning disabilities in some kids?
Date:8/29/2012

ANN ARBOR, Mich. A drug originally developed to stop cancerous tumors may hold the potential to prevent abnormal brain cell growth and learning disabilities in some children, if they can be diagnosed early enough, a new animal study suggests.

The surprising finding sets the stage for more research on how anti-tumor medication might be used to protect the developing brains of young children with the genetic disease neurofibromatosis 1 -- and other diseases affecting the same cellular signaling pathway.

The findings, made in mice, are reported in the journal Cell by scientists at the University of Michigan Medical School and their colleagues. The results are also important to understanding the stem cells that become different brain cells.

Neurofibromatosis 1, or NF1, affects one in every 3,000 children, and causes benign tumors to grow throughout the body, large head size and other issues. Many children with NF1 also struggle with learning to read, write, do math and behave well.

This impact on brain function is considered the most common serious issue caused by NF1, and often appears before other symptoms, except for brown patches on the skin that are often mistaken for birthmarks. But while the tumors that erupt mostly later in life have been well-studied, NF1's effect on brain function isn't understood.

In the new paper, the team studied neural stem cells a kind of master cell that can become any type of neural tissue. In newborn mice with two copies of the genetic mutation that causes NF1, neural stem cells in a key area of the brain were far more likely to produce a kind of "helper" nerve cell called glia. They produced far fewer cells called neurons, which send and receive crucial signals in the brain and body.

The scientists then took aim at this abnormal cell growth by giving the mice an experimental drug that has already been used in clinical trials for advanced cancer. Called PD0325901,
'/>"/>

Contact: Kara Gavin
kegavin@umich.edu
734-764-2220
University of Michigan Health System
Source:Eurekalert  

Page: 1 2 3 4

Related medicine news :

1. New traffic light test could save lives with earlier diagnosis of liver disease
2. Not all lung cancer patients who could benefit from crizotinib are identified by FDA-approved test
3. Study of tribe could help find East Asian skin color genes
4. Lifestyle changes could prevent 400 cardiac events and 200 deaths in Swedish PCI patients
5. Could Your Genes Influence How You Vote?
6. Stopping Controversial Asthma Drugs Could Have Downside: Study
7. Tests show that adhesive could improve safety of LASIK eye surgery
8. Missing Follow-Up Colonoscopies Could Raise Colon Cancer Risk
9. West Nile Outbreak Could Be Biggest Ever: CDC
10. Could Food Flavors Act Like Mood-Stabilizing Drugs?
11. DNA wires could help physicians diagnose disease
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Could a cancer drug potentially prevent learning disabilities in some kids?
(Date:9/22/2014)... York, New York (PRWEB) September 22, 2014 ... filed against Boston Scientific Corp. continue to move ... in U.S. District Court, Southern District of West ... documents, a new Docket Control Order was issued ... a number of matters pertaining to the upcoming ...
(Date:9/22/2014)... to 40 percent of patients undergoing breast cancer surgery ... all the cancerous tissue in the initial operation. However, ... tested a tool they developed that will help surgeons ... decreasing the chances for repeat operations. ... September 22, 2014 in the Proceedings of the ...
(Date:9/22/2014)... PA (PRWEB) September 22, 2014 An ... for patients to the problem of side-sleeping. "My lower ... side, so I designed a solution to this problem," ... asleep comfortably than to have your arm 'fall asleep.'" ... on his or her side more comfortably. It avoids ...
(Date:9/22/2014)... 2014 The R&D of cancer vaccines ... The statistically important data received from clinical research studies ... The primary challenge to the development of such vaccines ... mechanism of how a human’s immune system works. The ... different individuals owing to known factors with genetics possibly ...
(Date:9/22/2014)... Barbara Bronson Gray HealthDay Reporter ... something every pregnant woman wonders: What can I do to ... taking iron supplements as prescribed may play a role in ... disorder (ASD). The researchers found that mothers of children ... supplements before and during pregnancy than those whose children seem ...
Breaking Medicine News(10 mins):Health News:Transvaginal Mesh Lawsuits Move Forward, With Issuance of New Order in Federal Boston Scientific Litigation, Bernstein Liebhard LLP Reports 2Health News:Transvaginal Mesh Lawsuits Move Forward, With Issuance of New Order in Federal Boston Scientific Litigation, Bernstein Liebhard LLP Reports 3Health News:Transvaginal Mesh Lawsuits Move Forward, With Issuance of New Order in Federal Boston Scientific Litigation, Bernstein Liebhard LLP Reports 4Health News:The fine line between breast cancer and normal tissues 2Health News:World Cancer Vaccines Market Landscape Examined by Kuick Research in New Study Published at MarketPublishers.com 2Health News:World Cancer Vaccines Market Landscape Examined by Kuick Research in New Study Published at MarketPublishers.com 3Health News:World Cancer Vaccines Market Landscape Examined by Kuick Research in New Study Published at MarketPublishers.com 4Health News:Could Low Iron Intake During Pregnancy Raise Autism Risk? 2Health News:Could Low Iron Intake During Pregnancy Raise Autism Risk? 3
... bleeding is three times more likely to occur in ... regular basis despite the safety profile of non-steroidal anti-inflammatory ... as early as three days after starting an ibuprofen ... one of the most favorable safety profiles of all ...
... fund ?28m for research in United Kingdom as part ... eradication of Malaria worldwide. Bill Gates along with his ... international projects for malaria eradication over the next five ... contributed to research of AIDS and cancer, while malaria, ...
... Abhay Bang and Rani Bang are the two Indian Doctors ... of Heroes of Global Health in solving problems in the ... // innovated basic programs, which has reduced the infant mortality ... founders of the Maharashtra-based Society for Education, Action and Research ...
... marrow injury is an early or predisposing event in ... recent // research which appears online on September 23 ... Myelodysplastic syndrome is a heterogeneous group ... or more hematopoietic lineages, clonal evolution and a tendency ...
... transient episodes of bilateral muscle weakness with areflexia ... to narcolepsy. Cataplexy is diagnosed based on clinical ... recently but their usefulness has been limited because ... , ,Used effectively even these screening tests ...
... at Yale University have discovered the 'DCDC2' gene associated ... of children around the world. // , ,The ... 6 according to the researchers. The researchers found that ... formation of brain circuits and this genetic alteration is ...
Cached Medicine News:Health News:Bill Gates to Fund ?28m for Malaria researc 2Health News:TWO India Doctors Listed in TIME for Contribution to Global Health 2Health News:Chromosome 6 has the Dyslexia Gene 2
(Date:9/22/2014)... CHICAGO, Ill. , Sept. 22, 2014 /PRNewswire/ ... data from several clinical studies evaluating potential new ... presented at the upcoming 2014 European Society of ... Madrid, Spain . Data being ... evaluating the safety and efficacy of veliparib (ABT-888), ...
(Date:9/22/2014)... DIEGO , Sept. 22, 2014 Arena Pharmaceuticals, ... company is scheduled to present a corporate overview and ... on Friday, September 26, 2014, at 11:30 a.m. Eastern ... Hotel in New York City . ... will be available under the investor relations section of ...
(Date:9/22/2014)... , September 22, 2014 ... Line Development Market by Product (Equipment, Media and Reagents), ... Engineering & Regenerative medicine, Toxicity Testing, Research, Drug ... published by MarketsandMarkets, analyzes and studies the major ... Browse 114 market data tables and 64 ...
Breaking Medicine Technology:AbbVie to Present Clinical Study Data on Potential New Oncology Medicines at the 2014 European Society of Medical Oncology Annual Meeting 2AbbVie to Present Clinical Study Data on Potential New Oncology Medicines at the 2014 European Society of Medical Oncology Annual Meeting 3AbbVie to Present Clinical Study Data on Potential New Oncology Medicines at the 2014 European Society of Medical Oncology Annual Meeting 4Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference 2Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference 3Cell Line Development Market Worth $3.96 Billion by 2019 2Cell Line Development Market Worth $3.96 Billion by 2019 3Cell Line Development Market Worth $3.96 Billion by 2019 4
... HOUSTON, Jan. 23, 2012  Spine Pain Management, Inc. (OTC.BB: SPIN.PK), ... pleased to update investors on recent developments.    ... The company will present and meet with investors ... The day,s event is in Las Vegas, Nevada.  The ...
... 23, 2012  VentiRx Pharmaceuticals, Inc., a biopharmaceutical company ... 8 (TLR8) agonists for the treatment of cancer, ... that VTX-2337, the Company,s lead small molecule, is ... VTX-2337 directly activates human myeloid dendritic cells (mDCs), ...
Cached Medicine Technology:Spine Pain Management, Inc. Provides Corporate Updates 2VentiRx Pharmaceuticals Publishes Preclinical Data of Novel TLR8 Agonist, VTX-2337, Supporting Its Potential as an Immunotherapeutic Approach in Cancer 2VentiRx Pharmaceuticals Publishes Preclinical Data of Novel TLR8 Agonist, VTX-2337, Supporting Its Potential as an Immunotherapeutic Approach in Cancer 3
High resolution, multi-frequency, HST version of the UST-987-7.5. Provides even greater image detail, better resolution, and penetration....
A rigid version of the popular flexible laparoscopic transducer. It has been proven that a rigid "lap transducer has great utility in the OR for being an extra lifting tool inside the abdomen....
This is a 3D transducer for endovaginal imaging in OB/GYN....
Super High Density, 120 field of view, angled handle, multi-frequency, convex endovaginal transducer....
Medicine Products: